日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47.

SGN-CD47M 的临床前开发:蛋白酶激活抗体技术可选择性地靶向先天免疫检查点受体 CD47 的肿瘤

Levengood Matthew R, Carosino Christopher M, Zhang Xinqun, Lucas Sasha, Ortiz David J, Westendorf Lori, Chin Alice P, Martin Arlan D, Wong Abbie, Hengel Shawna M, Sun Hao, Zeng Weiping, Yumul Roma, Dominguez Melissa M C, Chen Yufei, Zheng Janet H, Karlsson Courtney A B, Trang Vivian H, Senter Peter D, Gardai Shyra J

Orthogonal Cysteine Protection Enables Homogeneous Multi-Drug Antibody-Drug Conjugates

正交半胱氨酸保护实现均一的多药抗体-药物偶联物

Levengood, Matthew R; Zhang, Xinqun; Hunter, Joshua H; Emmerton, Kim K; Miyamoto, Jamie B; Lewis, Timothy S; Senter, Peter D

Comparing Galactan Biosynthesis in Mycobacterium tuberculosis and Corynebacterium diphtheriae.

比较结核分枝杆菌和白喉棒状杆菌中半乳聚糖的生物合成

Wesener Darryl A, Levengood Matthew R, Kiessling Laura L

A processive carbohydrate polymerase that mediates bifunctional catalysis using a single active site

一种利用单个活性位点介导双功能催化的连续性碳水化合物聚合酶

May, John F; Levengood, Matthew R; Splain, Rebecca A; Brown, Christopher D; Kiessling, Laura L

Lacticin 481 synthetase as a general serine/threonine kinase

乳酸菌素481合成酶作为一种通用丝氨酸/苏氨酸激酶

You, Young Ok; Levengood, Matthew R; Ihnken, L A Furgerson; Knowlton, Aaron K; van der Donk, Wilfred A

Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids

利用非蛋白源氨基酸研究乳酸菌素481合成酶的底物特异性

Levengood, Matthew R; Kerwood, Christopher C; Chatterjee, Champak; van der Donk, Wilfred A

Use of lantibiotic synthetases for the preparation of bioactive constrained peptides

利用兰硫肽合成酶制备生物活性限制肽

Levengood, Matthew R; van der Donk, Wilfred A